An antiviral role for poly(ADP-ribosyl)ation

聚(ADP-核糖基)化的抗病毒作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Recent work has demonstrated that viruses have a complex and antagonistic relationship with host cells. Viruses have evolved proteins to exploit host proteins and cellular pathways to guarantee successful infection. In turn, host cells have evolved restriction factors to directly inhibit viral replication. As a result of this ancient and on-going conflict, the host and viral genes at the center of the conflict are evolving under positive selection. By studying the evolutionary history of host genes, we can identify new host antiviral genes and uncover the nature of their interaction with viruses. I have used evolutionary approaches to demonstrate that the gene, Zinc-finger Antiviral Protein, or ZAP, is evolving under positive selection in primates, suggesting it has a role in primate host defense. Further, my work implicates the PARP domain of ZAP as being at the interface of the conflict between ZAP and the virus. My proposal focuses on using functional assays to determine if human ZAP has antiviral activity and more specifically to address the role of the PARP domain in viral restriction. I will test primate ZAP isoforms with and without the PARP domain in cells challenged by MLV or HIV infection. I will also generate a version of human ZAP with a catalytically dead PARP domain to determine whether poly(ADP)ribosylation activity is necessary for restrictive capabilities. These studies will help to elucidate the mechanism by which ZAP restricts viruses and provide a model for poly(ADP)ribosylation in host defense. There are 16 other PARP containing genes and given the role of ZAP in host defense, I have performed a cursory survey of other PARP genes to identify other antiviral candidates. Indeed, 5 of these genes show signatures of positive selection and the other goal of my research plan is to perform a thorough evolutionary analysis of these genes in order to better understand the selective forces driving their evolution. RELEVANCE TO PUBLIC HEALTH Using the power of evolutionary methods and functional assays to explore the host-virus conflict will reveal how viruses successfully infect cells and how host cells are able to prevent viral infection. The results of this work will shed light on efforts to design antiviral therapeutics in the treatment of AIDS and other viral diseases.
描述(由申请人提供):最近的工作表明,病毒与宿主细胞具有复杂而拮抗的关系。病毒已进化出蛋白质来利用宿主蛋白和细胞途径以保证成功感染。反过来,宿主细胞具有进化的限制因子,以直接抑制病毒复制。由于这种古老而持续的冲突,冲突中心的寄主和病毒基因正在积极选择下发展。通过研究宿主基因的进化史,我们可以鉴定出新的宿主抗病毒药基因并揭示其与病毒相互作用的性质。我已经使用了进化方法来证明基因,锌指抗病毒蛋白或ZAP在灵长类动物的阳性选择下正在发展,这表明它在灵长类动物的宿主防御中起作用。此外,我的工作意味着ZAP的PARP领域处于ZAP与病毒之间冲突的界面。我的建议着重于使用功能测定来确定人ZAP是否具有抗病毒活性,并且更具体地解决了PARP域在病毒限制中的作用。我将测试有或没有MLV或HIV感染挑战的细胞中具有PARP结构域的灵长类动物ZAP同工型。我还将生成具有催化死亡PARP结构域的人类ZAP版本,以确定poly(ADP)核糖基化活性是否对于限制性功能是必需的。这些研究将有助于阐明ZAP限制病毒的机制,并为宿主防御中的聚(ADP)核糖化提供模型。还有16个包含基因的PARP,并鉴于ZAP在宿主防御中的作用,我对其他PARP基因进行了粗略的调查,以识别其他抗病毒药候选。的确,这些基因中的5个显示出肯定选择的特征,而我的研究计划的另一个目标是对这些基因进行彻底的进化分析,以便更好地了解推动其进化的选择性力量。使用进化方法和功能测定的力量探索宿主病毒冲突的功能将揭示病毒如何成功感染细胞以及宿主细胞如何预防病毒感染。这项工作的结果将阐明在治疗艾滋病和其他病毒疾病时设计抗病毒治疗剂的努力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie Ann Bletz其他文献

Julie Ann Bletz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie Ann Bletz', 18)}}的其他基金

Multi-Consortia Coordinating Center (MC2 Center) for Cancer Biology: Building Interdisciplinary Scientific Communities, Coordinating Impactful Resource Sharing, and Advancing Cancer Research
癌症生物学多联盟协调中心(MC2 中心):建立跨学科科学社区、协调有影响力的资源共享并推进癌症研究
  • 批准号:
    10525124
  • 财政年份:
    2022
  • 资助金额:
    $ 3万
  • 项目类别:
Assuring AI/ML-readiness of digital pathology in diverse existing and emerging multi-omic datasets through quality control workflows
通过质量控制工作流程,确保现有和新兴的多组学数据集中数字病理学的 AI/ML 就绪性
  • 批准号:
    10841333
  • 财政年份:
    2022
  • 资助金额:
    $ 3万
  • 项目类别:
Spatial Transcriptomics Explorer (STE): An open-source resource for visualizing spatial gene expression data
Spatial Transcriptomics Explorer (STE):用于可视化空间基因表达数据的开源资源
  • 批准号:
    10830668
  • 财政年份:
    2022
  • 资助金额:
    $ 3万
  • 项目类别:
Coordinating Sustainable Open Resource Sharing and Collaboration in Cancer Research
协调癌症研究中的可持续开放资源共享与合作
  • 批准号:
    10400971
  • 财政年份:
    2016
  • 资助金额:
    $ 3万
  • 项目类别:

相似海外基金

Novel nucleosome composition and modifications in protozoal parasite Toxoplasma g
原生动物寄生虫弓形虫 g 的新型核小体组成和修饰
  • 批准号:
    8113176
  • 财政年份:
    2009
  • 资助金额:
    $ 3万
  • 项目类别:
Novel nucleosome composition and modifications in protozoal parasite Toxoplasma g
原生动物寄生虫弓形虫 g 的新型核小体组成和修饰
  • 批准号:
    7897813
  • 财政年份:
    2009
  • 资助金额:
    $ 3万
  • 项目类别:
Novel nucleosome composition and modifications in protozoal parasite Toxoplasma g
原生动物寄生虫弓形虫 g 的新型核小体组成和修饰
  • 批准号:
    7688473
  • 财政年份:
    2009
  • 资助金额:
    $ 3万
  • 项目类别:
Novel nucleosome composition and modifications in protozoal parasite Toxoplasma g
原生动物寄生虫弓形虫 g 的新型核小体组成和修饰
  • 批准号:
    8304864
  • 财政年份:
    2009
  • 资助金额:
    $ 3万
  • 项目类别:
Molecular Recognition by Clathrin Adaptors
网格蛋白适配器的分子识别
  • 批准号:
    7593549
  • 财政年份:
  • 资助金额:
    $ 3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了